Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | Jin Gao, Yuan Yuan, Lili Zhang, Shaorong Yu, Jianwei Lu, Jifeng Feng, Sainan Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Cancer Cell International |
Online Access: | https://doi.org/10.1186/s12935-021-01759-5 |
Similar Items
-
Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
by: Jin Gao, et al.
Published: (2020-03-01) -
Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation
by: M. C. Martinez-Campanario, et al.
Published: (2023-12-01) -
The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2
by: Chiara Ninfali, et al.
Published: (2023-10-01) -
Expression and Function of ZEB1 in the Cornea
by: Yingnan Zhang, et al.
Published: (2021-04-01) -
Retraction Note: Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis
by: Jihua Han, et al.
Published: (2024-06-01)